The subpoena was disclosed by Sanofi in its filing with the Securities and Exchange Commission. All three drugmakers are complying with the probe, according to the report.
The subpoenas come as scrutiny grows over the price of the lifesaving diabetes drug. In recent months the Senate Finance Committee has launched an investigation into the price of insulin; Minnesota and Kentucky filed lawsuits accusing the drugmakers of artificially raising drug prices, and Colorado passed a law capping the price of insulin at $100 per month.
More articles on pharmacy:
Pfizer to merge off-patent business with Mylan
Senate panel advances drug-pricing legislation
Clinics leaving family planning program may have to toss thousands of dollars worth of drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
